MedPath
FDA Approval

Brimonidine Tartrate and Timolol Maleate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 31, 2023
Labeling Type
Human Prescription Drug Label
Brimonidine(2 mg in 1 mL)
Timolol(5 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alembic Pharmaceuticals Limited (F3)

Alembic Pharmaceuticals Limited

675480734

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brimonidine Tartrate and Timolol Maleate

Product Details

NDC Product Code
46708-706
Application Number
ANDA215230
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
August 31, 2023
Code: 4S9CL2DY2HClass: ACTIBQuantity: 2 mg in 1 mL
TimololActive
Code: P8Y54F701RClass: ACTIMQuantity: 5 mg in 1 mL
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACT
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4BClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath